Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: The lose of Brian and Wolf will hurt the value of this message board.

"Not quite understanding why you would think TPL can just bill PDS more because there is more in the bank or more available."

I hope you can take a little info from a "slimy" poster like me, but perhaps you explain how what you posted and what PTSC includes in its SEC filings relate to each other. TIA.

"PDS has committed to pay a quarterly amount ranging between $500,000 and $1,000,000 ( based upon a percentage of the working capital fund balance of PDS) for supporting efforts to secure licensing agreements by TPL on behalf of PDS.

Share
New Message
Please login to post a reply